Home Other Building Blocks 2-Ethyl-6-methyl-3-hydroxypyridine hydrochloride

2-Ethyl-6-methyl-3-hydroxypyridine hydrochloride

CAS No.:
13258-59-8
Catalog Number:
AG0010VR
Molecular Formula:
C8H12ClNO
Molecular Weight:
173.6400
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
95%
In Stock USA
United States
$350
- +
Product Description
Catalog Number:
AG0010VR
Chemical Name:
2-Ethyl-6-methyl-3-hydroxypyridine hydrochloride
CAS Number:
13258-59-8
Molecular Formula:
C8H12ClNO
Molecular Weight:
173.6400
MDL Number:
MFCD00460776
IUPAC Name:
2-ethyl-6-methylpyridin-3-ol;hydrochloride
InChI:
InChI=1S/C8H11NO.ClH/c1-3-7-8(10)5-4-6(2)9-7;/h4-5,10H,3H2,1-2H3;1H
InChI Key:
KZUIXWYHQJZUOK-UHFFFAOYSA-N
SMILES:
CCc1nc(C)ccc1O.Cl
UNII:
SN1FWZ77AE
Properties
Complexity:
105  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
173.061g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
173.64g/mol
Monoisotopic Mass:
173.061g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
33.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
[Effectiveness of 3-hydroxypyridine and succinic acid derivatives in complex treatment of primary open-angle glaucoma]. Eksperimental'naia i klinicheskaia farmakologiia 20120101
Effect of pro- and antioxidants on insulin sensitivity and glucose tolerance. Bulletin of experimental biology and medicine 20110101
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Efficiency of emoxipine in treatment of multiple organ failure in newborns]. Eksperimental'naia i klinicheskaia farmakologiia 20100901
[Effects of 3-hydroxypyridine and succinic acid derivatives on the dynamics of dorsalgia and affective disorders after surgical treatment of disc herniation]. Eksperimental'naia i klinicheskaia farmakologiia 20100101
[Effects of 3-hydroxypyridine and succinic acid derivates on the dynamics of vertebral/neurologic symptoms after the surgical treatment of disk herniations]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[Antidepressant action of emoxipin and mexidol in mice with alloxan diabetes]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[HPLC-MS determination of 2-ethyl-6-methyl-3-oxypyridine]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Effect of ascorbic acid and emoxypine on the dynamics of the quantitative roentgenological and clinical semiology parameters during infiltrative tuberculosis of lungs]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Effect of ascorbic acid and emoxypin on the efficiency of complex chemotherapy for infiltrative pulmonary tuberculosis]. Terapevticheskii arkhiv 20090101
Effect of succinic acid and tween-80 on glucuronidation of 2-ethyl-6-methyl-3-hydroxypyridine. Bulletin of experimental biology and medicine 20080701
The use of emoxipin for correction of cyclophosphamide cytotoxicity in experimental animals. Bulletin of experimental biology and medicine 20080701
[The effect of rubomycin, mexidol and emoxypine on some metabolic indexes and the proccess of spontaneous metastasis under conditions of experimental neoplasia]. Eksperimental'naia i klinicheskaia farmakologiia 20070101
[The influence of 3-oxypyridine antioxidants on depression in patients with diabetes mellitus]. Klinicheskaia meditsina 20070101
[The efficacy of complex therapy of ventricular arrhythmias with emoxipin and preductal in combination with antiarrhythmic agents]. Klinicheskaia meditsina 20070101
[The effectiveness of ascorbic acid and emoxipin in treatment of infiltrative pulmonary tuberculosis]. Klinicheskaia meditsina 20070101
[Pharmacological correction of neuronal damage in sensomotor zone of frontal cortex under conditions of experimental cerebral blood flow pathology]. Eksperimental'naia i klinicheskaia farmakologiia 20070101
[Morphofunctional status of gonadotropic cells of the adenohypophysis at early stages of age involution]. Advances in gerontology = Uspekhi gerontologii 20070101
[Effect of mexicor on oxidative stress in acute myocardial infarction]. Kardiologiia 20050101
[Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome]. Terapevticheskii arkhiv 20050101
[Antioxidant therapy in combined treatment of postoperative intestinal paresis]. Khirurgiia 20040101
[Efficacy of cytoprotective agent Mexicor in urgent cardiology]. Terapevticheskii arkhiv 20040101
[The enzyme therapy within a complex treatment of hemophthalmos in patients with diabetes mellitus]. Vestnik oftalmologii 20040101
[Clinical and biochemical manifestations of chronic pyelonephritis and their correction in population of the northen areas of the Tyumen Territory]. Terapevticheskii arkhiv 20040101
[Efficacy of emoxypine in combined therapy for elderly patients with postinfarct cardiosclerosis and heart failure]. Klinicheskaia meditsina 20040101
[Clinico-functional efficacy of medicinal and photon stabilization of cell membrane in patients with angina pectoris]. Klinicheskaia meditsina 20030101
[Effects of complex therapy with emoxipin on the course of diabetic retinopathy]. Vestnik oftalmologii 20030101
[Effect of alpha-tocopherol and synthetic antioxidants on morpho-functional status of gonadotropic cells from the adenohypophysis of albino rats]. Tsitologiia 20030101
[Emoxipin in combined pharmacological defense of the kidney from ischemia and operative stress (an experimental study)]. Urologiia (Moscow, Russia : 1999) 20030101
[Effect of mexidol, emoxypine, and dimephosphon on electrophysiological effects of nibentan]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[Neurophysiological analysis of the effects of antihypoxic versus psychotropic agents]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20020101
[Effect of emoxypine on myocardial electrical instability and homeostasis parameters in patients with acute disturbance of cerebrovascular circulation]. Eksperimental'naia i klinicheskaia farmakologiia 20020101
[Antioxidant properties of 3-oxypyridine analogues: mexidol, emoxipin, proxipin]. Voprosy meditsinskoi khimii 20010101
[Comparative evaluation of the antioxidant activity of para-aminobenzoic acid and emoxipin in the cornea and crystalline lens (an experimental study)]. Vestnik oftalmologii 20010101
[Prognostic significance of local and systemic indicators of lipid peroxidation and antioxidant system in perforating wounds of the eyes and their time course during local antioxidant treatment]. Vestnik oftalmologii 20010101
[Cardioprotective effect of drugs with antioxidant activity in acute cerebral ischemia]. Eksperimental'naia i klinicheskaia farmakologiia 20010101
Properties